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Purpose or Objective: Whole brain radiotherapy (WBRT) has 
been the treatment of choice for patients with brain 
metastases. However, change/decline of neurocognitive 
functions (NCFs) resulting from impaired hippocampal 
neurogenesis might occur after WBRT. It is reported that 
hippocampal sparing would provide the preservation of NCFs. 
Our study aims to investigate the correlations between 
hippocampal dosimetry and neurocognitive outcomes in 
patients receiving hippocampal sparing during WBRT (HS-
WBRT). 
 
Material and Methods: Fifty prospectively recruited cancer 
patients underwent HS-WBRT for therapeutic or prophylactic 
purposes. Before receiving HS-WBRT, all participants 
received a battery of baseline neurocognitive assessment, 
including memory, executive functions and psychomotor 
speed. The follow-up neurocognitive assessment at 4 months 
after HS-WBRT was also performed. To deliver HS-WBRT, 
Volumetric Modulated Arc Therapy (VMAT) with two full arcs 
and two non-coplanar partial arcs was employed. For each 
treatment planning, dose volume histograms were generated 
for left hippocampus, right hippocampus, and the composite 
hippocampal structure respectively. Biologically equivalent 
doses in 2-Gy fractions (EQD2) assuming an alpha/beta ratio 
of 2 Gy were computed. To perform analyses addressing the 
correlation between hippocampal dosimetry and the change 
in NCF scores, pre- and post-HS-WBRT neurocognitive 
assessments were available in 32 patients. 
 
Results: NCF scores were quite stable before and after HS-
WBRT regarding hippocampus-dependent memory. For verbal 
memory, the corresponding EQD2 values of 0%, 10%, 50%, 80% 
irradiating the composite hippocampal structure with 
<12.60Gy, <8.81Gy, <7.45Gy and <5.83Gy respectively were 
significantly associated with neurocognitive preservation 
indicated by the immediate recall of Word List Test of 
Wechsler Memory Scale-III. According to logistic regression 
analyses, it showed that dosimetric parameters specific to 
left hippocampus exerted an influence on immediate recall 
of verbal memory (adjusted odds ratio, 4.08; p-value, 0.042, 
predicting patients’ neurocognitive decline after HS-WBRT). 
 
Conclusion: Functional preservation by hippocampal sparing 
during WBRT is indeed achieved in our study. Providing that 
modern VMAT techniques can reduce the dose irradiating 
bilateral hippocampi below dosimetric threshold, patients 
should be recruited in prospective trials of hippocampal 
sparing during cranial irradiation to accomplish 
neurocognitive preservation while maintaining intracranial 
control. 
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Purpose or Objective: Ongoing clinical trials are evaluating 
advantage of hippocampal avoiding whole brain radiotherapy 
(WBRT), however, further basic research focusing on in-vivo 
description of radiation injury processes is still needed. Using 
magnetic resonance spectroscopy (MRS), it is possible to 
measure specific metabolite concentrations in any region of 
interest in the brain. N-acetylaspartate (NAA) represents a 
marker of viable neurons. To describe hypothesized post- 
WBRT neuronal depletion in hippocampus, we prospectively 
measured changes in NAA concentrations 4 months after 
WBRT. 
 
Material and Methods: Patients referred for WBRT with 
favorable prognosis estimated by graded prognostic 
assessment and without MRI hippocampal pathology were 
eligible for study enrollment. Before standard WBRT (two-
dimensional planning, 2 laterolateral 6 megavoltage fields, 
dose 10x3.0 Gy delivered by linear accelerator), hippocampal 
spectroscopy was performed using GE Medical Systems 
Discovery MR 750 3T. Region of interest was placed through 
the whole temporal lobi with the voxel layer position 
adjusted based on the localization of hippocampi. Specialized 
software was utilized for measurement of absolute NAA 
concentration in voxels within right, left and both 
hippocampi. The controle MRS with the same setup 
parameters was performed 4 months after the end of course 
of WBRT. Wilcoxon’s signed rank test was employed for 
calculation of NAA concentration changes. 
 
Results: Thirty-five patients (68% mens, mean age 59.5) were 
enrolled and underwent baseline MRS while only 18 (51%) of 
them finished the whole protocol with control measurement 
(15 died before and 2 refused). The most common primary 
cancer was lung (44%), kidney (20%) and breast (15%). On 
average, 9 voxels were analyzed per right and left 
hippocampus. The mean NAA concentration pre- and post-
WBRT was 8.47 [mM] and 7.43 [mM] for the right and 8.80 
[mM] and 8.04 [mM] for the left hippocampus, respectively. 
The statistically significant decrease was observed in the 
right (-11.4%; 95% confidence interval -6.9 to -15.9; 
p=0.0003) as well as in the left (-8.5%; 95% confidence 
interval -2.9 to -14.0; p=0.0034) hippocampus. 
 
Conclusion: Hippocampal MR spectroscopy is feasible and 
sensitive method for non-invasive measurement of brain radio 
injury. In our study, we observed correlation between left 
hippocampal N-acetylaspartate concentration and verbal 
memory decline with smaller effect of right hippocampus. 
Robust analysis of pre-irradiation imaging studies may 
provide valuable predictive biomarkers for decision making 
for the best radiotherapy approach in the treatment of brain 
metastases. 
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Purpose or Objective: To establish dose–volume effect 
correlations for late small bowel toxicities in patients treated 
for locally advanced cervical cancer with concomitant 
chemoradiation followed by MRI-guided adaptive 
brachytherapy. 
 
Material and Methods: In a cohort of patients treated in 
curative intent and followed prospectively, those who had 
completed the treatment one year before were retained for 
this study. The small bowel loops were delineated during the 
planning process, but no specific dose constraint was applied. 
The dosimetric data, converted in 2 Gy equivalent (α/β=3) 
were confronted to the occurrence of small bowel events: 
diarrhea, pain, flatulence, bleeding, obstruction, and fistula. 
Patients were followed every 3 months for the first year then 
every 6 months, for 3 years, then annually. Late morbidity 
was defined over the threshold of 90 days from treatment 
initiation and assessed using the CTC-AE 3.0. Patients who 
experienced recurrences were censored from the date of 
their relapse. Dose-effect relationships were assessed using 
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mean dose comparisons (T-pair and Kruskal-Wallis tests), log 
rank tests on event-free survivals, and probit analyses. The 
highest graded event, or in cases of similar grade the 
earliest, was considered for analyses. 
Results: One hundred and fifteen patients were eligible. Of 
them, 94.8% received concomitant chemoradiotherapy; 12.2% 
extended-field radiotherapy, and 32.2% nodal sequential 
boost. Their mean age was 47.5 years. The median follow-up 
was 35.5 months. A total of 522 events was reported. 
Focusing on the highest grade per patient: 17 had grade 0, 
75, grade 1, 20, grade 2 and 3, grade 3. The prevalence of 
grade 1 events appeared stable during the study period, 
ranging between 31.2 and 50%. The one of grade 2 events 
tended to worsen: 2.2% at 6 months, 4.5% at 1 year, 6.9% at 2 
years, and 7.0% at 3 years. Incidences of grade 2-4 events 
were 0.9% at 6 months, 6.6%, 19.0%, and 27.2% at 1, 2, 3 
years respectively. The mean D2cm3 and D0.1cm3 were 
respectively 68.7±13.6 Gy and 85.8±33.1 Gy and did not 
differ according to grade (p=0.47 and p=0.52). Comparisons 
of mean D2cm3 and D0.1cm3 according to grade 0-1 versus 2-
4 were not significant (68.0±12.4 vs 71.4±17.7 Gy, p=0.38 and 
83.7±26.4 vs 94.5±51.9 Gy, p=0.33 respectively). Log rank 
tests were performed after splitting patients into 4 groups 
according to D2cm3 levels: > 80 Gy, 70 to 79 Gy, 60 to 70 Gy 
and < 60 Gy. No difference was observed for grade 1-4 
(p=0.52), grade 2-4 (p=0.52) or grade 3-4 (p=0.21). Probit 
analyses showed no correlation between both dosimetric 
parameters and the probability of small bowel events grade 
1-4, 2-4, or 3-4 (p ranging from 0.19 to 0.48).  
 
Conclusion: No significant dose–volume effect relationships 
were demonstrated between the D2cm3 and D0.1cm3 and the 
probability of late small bowel morbidity. These two 
parameters should not limit the optimization process. 
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Purpose or Objective: Brachytherapy is a well-established 
radiotherapy treatment modality that has been employed in 
treatments of several cancer types for more than a century. 
One of the most common treatment strategies for cervical 
cancer today is a combination of external beam radiotherapy, 
chemotherapy and brachytherapy. Similar to other forms of 
radiation therapy, pre-treatment imaging of hypoxia is rarely 
done for cervical cancer. Nevertheless, the clinical outcome 
is highly positive, despite the fact that hypoxia has been 
repeatedly confirmed in cervical tumours. It was therefore 
the purpose of this study to investigate whether the success 
of brachytherapy in these tumours, seemingly regardless of 
oxygenation status, could be explained by the characteristics 
of the brachytherapy dose distributions in comparison to 
external beam radiotherapy. 
 
Material and Methods: A previously used in silico model of 
tumour oxygenation and radiation response was further 
developed to simulate the treatment of cervical cancer 
employing the combination of external beam radiotherapy 
and intracavitary brachytherapy. Based on the local clinical 
protocol and using a clinically derived brachytherapy dose 
distribution and assuming a homogeneous dose delivered by 
external radiotherapy, survival was assessed on voxel level 
taking into account the dose-modifying effect of the 
oxygenation as well as the effects of repair and repopulation 
of tumour cells during treatment. Two scenarios were 
considered for brachytherapy: one in which the high dose 
region was highly conformal to the hypoxic region in the 
target and one in which they were displaced relative to each 
other. Overall-response was assessed as Poisson-based 
tumour control probability (TCP). The interplay between 
tumour oxygenation and the heterogeneous high-dose 
distribution was also studied by simulating different spatial 
and temporal patterns of hypoxia. The results were compared 
to the case when irradiation was performed only with 
external beams delivering a homogeneous dose to the target. 
 
Results: Predicted values of D50 with respect to the external 
treatment and assuming reoxygenation were in agreement 
with the clinically observed high cure rates. Assuming fast 
reoxygenation, the D50 was similar for the different cases of 
overlap between the brachytherapy dose distribution and the 
tumour, regardless if the hypoxic fraction was 10% or 25% 
(Table 1). To achieve 50% control with external RT only, a 
total dose of more than 70 Gy in 25 fractions would be 
required for both cases of hypoxic fraction assuming 
reoxygenation (Figure 1). 
 
 
 
 
Conclusion: Assuming fast reoxygenation, the dependence on 
the degree and extent of hypoxia has little impact on the 
outcome and therefore the high doses delivered in 
brachytherapy could counteract the negative impact of 
hypoxia. 
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Purpose or Objective: Post hysterectomy vaginal vault 
recurrences have poor outcomes with pelvic control rates 
ranging from 50-60%. We conducted this prospective study at 
our centre with an aim to determine the factors influencing 
